---
layout: post 
title: "OpenEvidence, the ‘ChatGPT for doctors,’ raises $200M at $6B valuation"
blog_url: https://techcrunch.com/2025/10/20/openevidence-the-chatgpt-for-doctors-raises-200m-at-6b-valuation/?utm_source=tldrai 
---



## Key Points

- OpenEvidence, an AI tool for medical professionals, has raised $200 million.
- This new funding round values the company at $6 billion.
- The platform is described as 'ChatGPT for medicine' and helps doctors and nurses quickly access medical knowledge for patient treatment.
- It's trained on prominent medical journals like JAMA and the New England Journal of Medicine.
- Verified medical professionals can use OpenEvidence for free, supported by advertising.
- OpenEvidence, founded in 2022, has seen rapid growth, with monthly clinical consultations nearly doubling to 15 million since July.
- Google Ventures led the funding round, with participation from several other major investment firms.

## Key Topics Discussed

Hey everyone, we've got some exciting news from the world of AI in healthcare! OpenEvidence, a groundbreaking AI platform that's been dubbed the 'ChatGPT for doctors,' has just secured a massive $200 million in its latest funding round. This new investment has propelled the company's valuation to an incredible $6 billion! This isn't just a big win for OpenEvidence; it really highlights the massive interest investors have in specialized AI applications, especially when they can make a real difference in critical fields like medicine. It's even more impressive when you consider they just raised $210 million at a $3.5 billion valuation just three months ago—talk about rapid growth! Founded in 2022, OpenEvidence is designed to be a crucial tool for doctors and nurses. It helps them quickly tap into a vast reservoir of existing medical knowledge, all thanks to being trained on top-tier medical journals like JAMA and the New England Journal of Medicine. This means medical professionals can get fast answers to help inform patient treatment. And here's a great part: verified medical professionals can use OpenEvidence for free, with the platform supported by advertising. The company has seen phenomenal growth, with its monthly clinical consultations nearly doubling to 15 million since July. This rapid adoption truly shows the impact it's having in the medical community. This latest round was led by Google Ventures, with a lot of other big names like Sequoia Capital and Kleiner Perkins jumping in as well. What a testament to the potential of AI to transform healthcare!

